Charles River Laboratories International shares are trading lower after the company reported Q2 financial results and cut its FY24 adjusted guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
Charles River Laboratories International shares are trading lower after the company reported Q2 financial results and cut its FY24 adjusted guidance below estimates.
August 07, 2024 | 11:29 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Charles River Laboratories International shares are trading lower after the company reported Q2 financial results and cut its FY24 adjusted guidance below estimates.
The company's shares are reacting negatively to the disappointing Q2 financial results and the reduction in FY24 adjusted guidance, which fell below market expectations. This indicates potential short-term downward pressure on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100